President Bush’s choice to head the Food and Drug Administration is refusing to give Congress all the information it seeks about a controversial antibiotic, setting up further confrontations with a Republican senator blocking his nomination.

The agency’s acting chief, Dr. Andrew von Eschenbach, said full disclosure of the information about Ketek could have a chilling effect on the FDA’s ability to be an independent and objective evaluator of drug safety and other issues.